Skip to main content

Lymphedema Epidemiology

  • Chapter
  • First Online:
Lymphedema
  • 2896 Accesses

Abstract

Lymphedema remains an under-recognised and under-resourced aspect of healthcare. It has been considered to be a rare condition, which causes little morbidity and cannot be treated.

It is therefore important to measure the prevalence and impact of lymphedema in different populations to be able to quantify the real healthcare needs of people with this condition.

Large population-based studies are difficult to carry out, but there are methods such as the case ascertainment approach, which allow the prevalence of lymphedema to be estimated. In all such studies, it is important that the population is well defined and a standard definition of the term lymphedema/chronic edema is used.

Using the definition of chronic edema as «edema of any body site present for at least 3 months», a study carried out in London revealed a crude prevalence of 1.33/1000. The prevalence was higher in those aged over 65 years. This study also demonstrated the significant impact of chronic edema on individuals.

A recent similar study carried out in the Midlands of the UK reported a crude prevalence of 3.93/1000. The difference between these results may be explained by differences in the characteristics of the populations or in the awareness of local healthcare professionals of the condition.

An international epidemiological study (LIMPRINT) is being carried out to estimate the prevalence and impact of chronic edema in a number of countries around the world in order to improve awareness and understanding of this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Highlighted References

  1. Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, Bosanquet N, Mortimer PS. Lymphedema: an underestimated health problem. QJM. 2003;96(10):731–8.

    Article  CAS  PubMed  Google Scholar 

  2. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(2):198–210. doi:10.1093/cvr/cvq062. Epub 2010 Mar 3.

    Article  CAS  PubMed  Google Scholar 

  3. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci. 2008;1131:147–54. http://onlinelibrary.wiley.com.ezproxy.nottingham.ac.uk/doi/10.1196/annals.1413.014/epdf.

  4. Moffatt CJ, Keeley V, Franks PJ, Rich A, Pinnington L. Chronic oedema: a prevalent health care problem for UK health services. Int Wound J. 2016. In Press.

    Google Scholar 

  5. Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, Cormier JN, Shih Y-CT. A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004–2011). Lymphology. 2013;46(1):27–41.

    CAS  PubMed  Google Scholar 

References

  1. Keeley V, Pinnington L, Riches K, Phillips M, Fakis A, Vaithianathar L, Jones M, Moffatt C. The prevalence of Chronic Lower Limb Oedema (CLLO) in Multiple Sclerosis (MS). San Francisco: Abstract World Congress of Lymphology; 2015.

    Google Scholar 

  2. Armer JM, Stewart BR, Shook RP. 30-month post-breast cancer treatment lymphoedema. J lymphoedema. 2009;4(1):14–8.

    PubMed  PubMed Central  Google Scholar 

  3. Bull RH, Gane JN, Evans JE, Joseph AE, Mortimer PS. Abnormal lymph drainage in patients with chronic venous leg ulcers. J Am Acad Dermatol. 1993;28:585–90.

    Article  CAS  PubMed  Google Scholar 

  4. Svensson WE, Mortimer PS, Tohno E, Cosgrove DO. Colour Doppler demonstrates venous flow abnormalities in breast cancer patients with chronic arm swelling. Eur J Cancer. 1994;30(5):657–60.

    Article  Google Scholar 

  5. Mellor RH, Brice G, Stanton AW, French J, Smith A, Jeffery S, Levick JR, Burnand KG, Mortimer PS. Lymphoedema research consortium. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007;115:1912–20.

    Article  CAS  PubMed  Google Scholar 

  6. Cooper G, Bagnall A. Prevalence of Lymphedema in the UK: a focus on the Southwest and West Midlands. 2016. British Journal of Community Nursing, MA HealthCare Limited Accessed via http://www.magonlinelibrary.com/doi/pdf/10.12968/bjcn.2016.21.Sup4.S6.

  7. Keast DH, Despatis M, Allen JO, Brassard A. Chronic edema/lymphedema: under-recognised and under-treated. Int Wound J. 2015;12(3):328–33.

    Article  PubMed  Google Scholar 

  8. Garcia AM, Dicianno BE. The frequency of lymphedema in an adult spina bifida population. Am J Phys Med Rehabil. 2011;90(2):89–96. ISSN 1537-7385.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vaughan Keeley .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Keeley, V., Moffatt, C. (2018). Lymphedema Epidemiology. In: Lee, BB., Rockson, S., Bergan, J. (eds) Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-319-52423-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52423-8_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52421-4

  • Online ISBN: 978-3-319-52423-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics